Safety evaluation of a novel variant of consensus bacterial phytase

• Main Authors: Gregory S. Ladics, Kang-Hyun Han, Min S. Jang, Heejin Park, Valerie Marshall, Yueming Dersjant-Li, Vincent J. Sewalt
• Format: Article
• Language: English
• Published: Elsevier 2020-01-01
• Series: Toxicology Reports
• Subjects: Phytase; NOAEL; Genetic toxicology; Subchronic study; Oral gavage
• Online Access: http://www.sciencedirect.com/science/article/pii/S2214750020303498

A 90-day subchronic oral toxicity study was conducted to evaluate the safety of a consensus bacterial phytase variant 6-phytase (PhyG) for use as an animal feed additive. This phytase is produced by fermentation with a fungal (Trichoderma reesei) production strain expressing a biosynthetic variant of a consensus bacterial phytase gene assembled via ancestral reconstruction with sequence bias for the phytase from Buttiauxella sp. Rats were administered PhyG daily via oral gavage at dose-levels of 0 (distilled water), 250, 500 or 1000 mg total organic solids (TOS)/kg bodyweight (bw)/day (equivalent to 0, 112,500, 225,000 and 450,000 phytase units (FTU)/kg bw/day, respectively). No test article-related adverse effects were observed. A no-observed-adverse-effect level (NOAEL) for PhyG was established as 1000 mg TOS/kg bw/day, the highest test concentration. Based on this NOAEL and an estimate of broiler consumption determined from the proposed inclusion of the phytase in feed at the maximum recommended level (4000 FTU/kg), a margin of safety value of 1613 was calculated. Results of in vitro genotoxicity testing and in silico protein toxin evaluation further confirmed PhyG to be non-genotoxic and not likely to be a protein toxin upon consumption. These data support the safety of PhyG as an animal feed additive.